Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons

被引:7
|
作者
Corenblum, M. J. [1 ]
McRobbie-Johnson, A. [2 ]
Carruth, E. [3 ]
Bernard, K. [2 ]
Luo, M. [4 ]
Mandarino, L. J. [4 ]
Peterson, S. [5 ]
Sans-Fuentes, M. A. [5 ]
Billheimer, D. [5 ]
Maley, T. [2 ]
Eggers, E. D. [6 ,7 ]
Madhavan, L. [1 ,8 ,9 ,10 ]
机构
[1] Univ Arizona, Dept Neurol, Tucson, AZ USA
[2] Univ Arizona, Physiol Sci Grad Program, Tucson, AZ USA
[3] Univ Arizona, Physiol Undergraduate Program, Tucson, AZ USA
[4] Univ Arizona, Dept Med, Tucson, AZ USA
[5] Univ Arizona, BIO5 Inst, Stat Consulting Lab, Tucson, AZ USA
[6] Univ Arizona, Dept Physiol, Tucson, AZ USA
[7] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA
[8] Univ Arizona, Evelyn McKnight Brain Inst, Tucson, AZ USA
[9] Univ Arizona, BIO5 Inst, Tucson, AZ USA
[10] Univ Arizona, Dept Neurol, 1501,N Campbell Ave, Tucson, AZ 85724 USA
关键词
Skin fibroblasts; Human Induced Pluripotent Stem Cells; Midbrain Dopamine Neurons; Aging; Parkinson 's disease; Mitochondrial Dysfunction; ALPHA-SYNUCLEIN; HUMAN ES; CELLS; MITOCHONDRIA;
D O I
10.1016/j.pneurobio.2023.102501
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Dopamine neurons exhibit emergent glutamatergic identity in Parkinson's disease
    Steinkellner, Thomas
    Conrad, William S.
    Kovacs, Imre
    Rissman, Robert A.
    Lee, Edward B.
    Trojanowski, John Q.
    Freyberg, Zachary
    Roy, Subhojit
    Luk, Kelvin C.
    Lee, Virginia M.
    Hnasko, Thomas S.
    BRAIN, 2022, 145 (03) : 879 - 886
  • [22] Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?
    Bjorklund, Anders
    Lindvall, Olle
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 : S23 - S33
  • [23] Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease
    Haddad, Dominik
    Nakamura, Ken
    FEBS LETTERS, 2015, 589 (24): : 3702 - 3713
  • [24] Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Olanow, CW
    Freeman, T
    Kordower, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 146 - 146
  • [25] Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons
    Ren, Yong
    Jiang, Houbo
    Pu, Jiali
    Li, Li
    Wu, Jianbo
    Yan, Yaping
    Zhao, Guohua
    Guttuso, Thomas J.
    Zhang, Baorong
    Feng, Jian
    MOVEMENT DISORDERS, 2022, 37 (01) : 70 - 79
  • [26] Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
    Xiong, Nian
    Xiong, Jing
    Khare, Ghanshyam
    Chen, Chunnuan
    Huang, Jinsha
    Zhao, Ying
    Zhang, Zhentao
    Qiao, Xian
    Feng, Yuan
    Reesaul, Harrish
    Zhang, Yongxue
    Sun, Shenggang
    Lin, Zhicheng
    Wang, Tao
    PLOS ONE, 2011, 6 (06):
  • [27] Preclinical Evaluation of iPSC-Derived Midbrain Dopaminergic Neurons for Parkinson's Disease
    Emborg, M. E.
    Tao, Y.
    Vermilyea, S. C.
    Metzger, J.
    Phillips, S.
    Resnikoff, H.
    Johnson, A.
    Boettcher, C.
    Brunner, K.
    Erickson, C.
    Bondarenko, V.
    Olsen, M.
    Block, W.
    Christian, B.
    Zammit, M.
    Holden, J.
    Zhang, S. -C.
    CELL TRANSPLANTATION, 2018, 27 (04) : 690 - 691
  • [28] Importance of parallel history in Parkinson's disease patients on dopamine agonists!
    Rana, A. Q.
    Fattah, A.
    Siddiqi, I.
    MOVEMENT DISORDERS, 2011, 26 : S260 - S260
  • [29] Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease
    Bayersdorfer, Florian
    Voigt, Aaron
    Schneuwly, Stephan
    Botella, Jose A.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 113 - 119
  • [30] PRESERVATION OF HYPOTHALAMIC DOPAMINE NEURONS IN PARKINSON DISEASE
    SAPER, CB
    FULLING, KH
    NEUROLOGY, 1982, 32 (04) : A181 - A181